Comparison

Camostat (mesylate) European Partner

Item no. HY-13512-25mg
Manufacturer MedChem Express
CASRN 59721-29-8
Amount 25 mg
Quantity options 100 mg 10 mM/1 mL 10 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.94
Citations [1]Gibo J, et al. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest. 2005;85(1):75‐89.|[2]Uno Y. Camostat mesilate therapy for COVID-19 [published online ahead of print, 2020 Apr 29]. Intern Emerg Med. 2020;1‐2.|[3]Coote K, et al. Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther. 2009;329(2):764‐774.|[4]Zhou Y, Vedantham P, Lu K, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76‐84.
Am J Physiol Renal Physiol. 2024 Aug 1;327(2):F265-F276.
Antiviral Res. 2023 Jun:214:105606.
Biochem Pharmacol. 2023 Jul:213:115617.
Biosaf Health. 2022 Feb;4(1):38-44.
Cell Discov. 2021 Dec 14;7(1):119.
Cell Prolif. 2025 May 15:e70060.
Cell Rep Med. 2022 Sep 20;3(9):100743.
Cell. 2023 Feb 16;186(4):850-863.e16.
EBioMedicine. 2023 Sep:95:104753.
Emerg Microbes Infect. 2022 Dec;11(1):2275-2287.
Eur J Med Chem. 2021 Nov 15:224:113683.
Eur J Pharmacol. 2022 Mar 15:919:174795.
Eur J Pharmacol. 2023 Jan 5:938:175394.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep.
J Virol. 2023 May 31;97(5):e0032423.
J Virol. 2025 Nov 18:e0127425.
mBio. 2022 Dec 20;13(6):e0256622.
Nat Chem Biol. 2022 Sep;18(9):963-971.
Nat Commun. 2022 Jul 26;13(1):4331.
Nat Commun. 2022 Mar 17;13(1):1444.
Nat Commun. 2024 Jul 3;15(1):5606.
Nat Commun. 2024 Oct 9;15(1):8728.
Nat Commun. 2025 Jul 7;16(1):6241.
Nat Microbiol. 2024 Sep;9(9):2383-2394.
Nat Microbiol. 2025 Oct 30,10(11):2860-2874.
Nature. 2022 Mar;603(7902):693-699.
Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121.
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2117576119.
Res Sq. 2023 Sep 11:rs.3.rs-3220157.
Res Sq. 2024 Nov 21.
Research Square Preprint. 2022 Jan.
Sci Adv. 2023 Jan 20;9(3):eadd3867.
Sci China Life Sci. 2025 Oct 24.
Sci Signal. 2024 Aug 20;17(850):eadn3785.
Signal Transduct Target Ther. 2022 Mar 11;7(1):83.
SSRN. 2020 Jun.
SSRN. 2024 Jan 26.
SSRN. 2024 Jul 11.
Utrecht University. CENTER FOR CELL IMAGING. 2022 Jul.
Viruses. 2022 Feb 8;14(2):353.
J Virol. 2025 Aug 11:e0105525.
PLoS Pathog. 2025 Oct 14;21(10):e1013593.
Smiles O=C(OCC(N(C)C)=O)CC1=CC=C(OC(C2=CC=C(NC(N)=N)C=C2)=O)C=C1.CS(=O)(O)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Camostat mesilate,FOY305,FOY-S980
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-Kinase/protease
Manufacturer - Category
Reference compound / Active compounds; API
Manufacturer - Targets
SARS-CoV; Ser/Thr Protease
Manufacturer - HS Code
H315, H319, H335, H400
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
494.52
Product Description
Camostat mesylate (Camostat mesilate) is an orally active, synthetic serine protease inhibitor for chronic pancreatitis. Camostat mesylate, an inhibitor of TMPRSS2, shows antiviral activity against SARS-CoV-2. Camostat mesylate also inhibits the activity of prostasin, trypsin, and matriptase[1][2][3].
Manufacturer - Research Area
Infection; Inflammation/Immunology
Solubility
DMSO : 125 mg/mL (ultrasonic)|H2O : ≥ 50 mg/mL
Manufacturer - Pathway
Anti-infection; Metabolic Enzyme/Protease
Clinical information
Launched
UNSPSC Code
12352005
Precautionary
H315, H319, H335, H400

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?